GC

GlucoTrack Inc

GCTK
Accountable AI Logo

GlucoTrack Inc AI Insights

Informational only. Not investment advice.
As of 2025-12-26

Snapshot

  • Zero revenue TTM with 14.9M cash burn - 7.9M cash provides ~6 months runway at current rate[Free Cash Flow TTM]
  • R&D of 9.9M is 60% of operating expenses (16.5M TTM) - pre-commercial stage company[Research and Development TTM]
  • Negative enterprise value (-793K) as cash exceeds market cap (3.8M) plus debt (3.3M)[Enterprise Value]

Watch Triggers

  • Cash and Equivalents: Falls below 4M or rises above 15MBelow 4M = 3-month runway crisis; above 15M = successful raise without fatal dilution
  • Shares Outstanding: Increases >50% from 899K baselineSignals dilutive financing magnitude - critical for per-share value
  • Total Revenue TTM: Any revenue recognition >0First revenue validates commercial viability and transforms investment thesis

Bull Case

Trading below net cash value - negative EV means market assigns zero value to IP/pipeline. Any positive clinical news creates asymmetric upside.

Enterprise ValueCash and Equivalents

R&D-heavy spend (9.9M TTM) suggests active development. Successful product could transform fundamentals given tiny 3.8M market cap.

Research and Development TTMMarket Cap TTM

Bear Case

6-month cash runway with zero revenue - dilutive financing or bankruptcy is near-certain without external capital or partnership.

Cash and EquivalentsFree Cash Flow TTM

Micro-cap (3.8M) with 12K daily volume - illiquid, high spread costs, institutional investors cannot participate.

Market Cap TTMVolume

Bull vs Bear Balance

AI-generated sentiment analysis based on fundamental metrics and market conditions.

BearBull
25%

Leverage GCTK's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.

Take Me to The Editor

Forward Thesis

Binary outcome: either secures funding/partnership or faces severe dilution within 6-9 months

3-12mhigh
  • Cash runway under 12 months at current burn
  • No revenue to offset operating losses
  • Debt/equity of 1.2x limits borrowing capacity
7.9M cash vs 14.9M annual FCF burn TTM3.3M total debt on 2.8M equity899K shares outstanding - dilution imminent

Valuation Context

Caveats

Public Strategies Rankings

See how GlucoTrack Inc ranks across different investment strategies.

Leverage GCTK's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.

Data Partners
Morningstar Logo

Fundamental company data provided by Morningstar, updated daily.

Accountable Finance, Inc. Disclaimer
accountable.finance is not operated by a broker or a dealer. Under no circumstances does any information posted on accountable.finance represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. In no event shall accountable.finance be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on accountable.finance, or relating to the use of, or inability to use, accountable.finance or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Stock quotes and fundamental company data provided by Morningstar, updated daily.

Accountable Logo
© 2026 Accountable Finance, Inc. All rights reserved.